Delivery Order SPE2DB22D2206-SPE2DB26FDS11
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,365.81 to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Topiramate ER 200 mg capsules (30-count units) with a ceiling value of $2,157.41. This is a firm fixed price, non-set-aside contract awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a ceiling value of $5,421.03. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters, with an ultimate completion date of August 26, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a contract ceiling value of $8,032.67. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.18 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count units) on October 16, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed price, non-set-aside contract for delivery to the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs....
- The Defense Logistics Agency awarded a delivery order valued at $5,717.72 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 200 mg capsules (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) with a ceiling value of $1,438.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,124.66 by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 4, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,882.48 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Topiramate ER 25 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations center. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,003.47. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS11Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for Topiramate ER 200 mg capsules (30-count units) with a ceiling value of $5,626.87. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle, enabling AmerisourceBergen to supply a wide range of products to support military healthcare programs worldwide and serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/20/25 |